Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression in PBMCs of patients with hepatocarcinoma: effect of ablative treatment - genes

ABSTRACT: Gene expression in PBMCs of patients with hepatocarcinoma: effect of ablative treatment - genes

PROVIDER: PRJNA598857 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Gene expression in PBMCs of patients with hepatocarcinoma: effect of ablative treatment - genes

Project description:Gene expression profiles of PBMCs in patients with hepatocarcinoma after ablative treatment. Results provide the information of changes in PBMPs transcriptome following ablative treatment of hepatocarcinoma.

2020-01-04 | GSE143004 | GEO

Human hepatocarcinoma cells : Huh-7 vs. SNU-739

Project description:Transcriptional profiling of human hepatocarcinoma comparing Huh-7 and SNU-739.

2014-04-29 | GSE57106 | GEO

The function of Oxytocin Receptor in the Tumorigenesis of Hepatocarcinoma

Project description:To investigate the function of Oxytocin Receptor in the Tumorigenesis of Hepatocarcinoma.

2024-01-31 | GSE249404 | GEO

Effect of antiretroviral prophylaxis on gene expression in PBMCs

Project description:Effect of antiretroviral prophylaxis on gene expression in PBMCs

| PRJNA586831 | ENA

Human hepatocarcinoma cells : Huh-7 vs. SNU-739

Project description:Transcriptional profiling of human hepatocarcinoma comparing Huh-7 and SNU-739. Two-condition experiment, normalized ratio represented by Huh-7/SNU-739. Biological replicates: 2 Huh-7 replicates, 2 SNU-739 replicates.

2014-04-29 | E-GEOD-57106 | biostudies-arrayexpress

PBMCs from metastatic breast cancer patients

Project description:PBMCs from metastatic breast cancer patients

| PRJNA730015 | ENA

Gene expression profile at single cell level of two TDT patients' PBMCs after gene editing treatment.

Project description:BCL11A encodes for a zinc-finger transcription factor that plays an important role in B-cell and pDC development. Although the +58 BCL11A enhancer we disrupted was reported as a erythroid specific enhancer, we needed to further evaluate the potential down regulation of BCL11A in other subpopulations of edited PBMCs. To study the transcriptional impact of BCL11A enhancer gene editing, we performed single-cell RNA sequencing (scRNA-seq) on PBMCs.

2022-05-29 | GSE204688 | GEO

PRDX6 as a promoter of cancer malignancy in hepatocarcinoma cell lines targeting GSK3B

Project description:This project describes the mechanism by wich PRDX6 affects migration and invasiveness in hepatocarcinoma cells. SNU475 (mesenchymal) hepatocarcinoma cell line knockout for PRDX6 showed a marked increase in ROS and lipid peroxidation, mytochondrial dysfunction, metabolic reprogramming, altered cytoskeleton and activation of upstream regulators MYC, ATF4, HNF4A and HNF4G and inhibition of NRF2 and TP53. All these changes point to a role of PRDX6 in tumor development pointing to it as a candidate for antitumoral therapies.

2023-07-20 | PXD039491 | Pride

Analysis of transcriptomic responses of genotoxic stress in human HepaRG hepatocarcinoma cells

Project description:Purpose: Toxicogenomics analyses may provide information about DNA-damaging properties of test compounds but are not routinely used for identification of a genotoxic potential. In this study, metabolically active human HepaRG hepatocarcinoma cells were exposed to six food-relevant genotoxic carcinogens. Method: Transcriptomic responses were analyzed using RNA sequencing technology

2020-04-16 | GSE146549 | GEO

PBMCs from patients with Sjögren's syndrome and healthy controls

Project description:Sjögren's syndrome is an autoimmune disease manifesting primarily as dryness of eyes and mouth. In this study, we compared gene expression in PBMCs between age- and gender-matched patients with Sjögren's syndrome (diagnosed by ACR criteria) and healthy controls. Cells were collected in heparinized tubes and PBMCs were prepared using Ficoll.

2013-09-05 | GSE48378 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data